HUT65445A - Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing them - Google Patents

Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing them

Info

Publication number
HUT65445A
HUT65445A HU9203812A HU9203812A HUT65445A HU T65445 A HUT65445 A HU T65445A HU 9203812 A HU9203812 A HU 9203812A HU 9203812 A HU9203812 A HU 9203812A HU T65445 A HUT65445 A HU T65445A
Authority
HU
Hungary
Prior art keywords
thiazolyl
methoxy
preparation
acetic acid
acid derivatives
Prior art date
Application number
HU9203812A
Other languages
English (en)
Inventor
Siegfried Raddatz
Romanis Fruchtmann
Reiner Mueller-Peddinghaus
Klaus-Helmut Mohrs
Armin Hatzelmann
Michael Matzke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HUT65445A publication Critical patent/HUT65445A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
HU9203812A 1991-12-03 1992-12-02 Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing them HUT65445A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4139751A DE4139751A1 (de) 1991-12-03 1991-12-03 Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
CA002061538A CA2061538A1 (en) 1991-02-22 1992-02-19 2-substituted quinolines, processes for their preparation and their use in medicaments

Publications (1)

Publication Number Publication Date
HUT65445A true HUT65445A (en) 1994-06-28

Family

ID=25674978

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9203812A HU9203812D0 (en) 1991-12-03 1992-12-02 Quinoline-metoxi-phenyl acetic acid derivatives substituted with thiazolyl group
HU9203812A HUT65445A (en) 1991-12-03 1992-12-02 Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU9203812A HU9203812D0 (en) 1991-12-03 1992-12-02 Quinoline-metoxi-phenyl acetic acid derivatives substituted with thiazolyl group

Country Status (10)

Country Link
US (1) US5283252A (hu)
EP (1) EP0549879A3 (hu)
JP (1) JPH05247036A (hu)
AU (1) AU660742B2 (hu)
CA (2) CA2061538A1 (hu)
DE (1) DE4139751A1 (hu)
FI (1) FI925469A (hu)
HU (2) HU9203812D0 (hu)
NZ (1) NZ245328A (hu)
ZA (1) ZA929330B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139750A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
JP2006508180A (ja) * 2002-10-17 2006-03-09 デコード ジェネティクス イーエッチエフ． 心筋梗塞に対する感受性遺伝子；治療の方法
EP1660427A4 (en) 2003-08-14 2006-12-20 Asahi Kasei Pharma Corp SUBSTITUTED ARYLALKANIC DERIVATIVE AND ITS USE
CA2547518A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
US8158362B2 (en) 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
CA2553928A1 (en) * 2004-01-30 2005-08-18 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and paod; methods of treatment
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
EP3906925A1 (en) 2014-02-04 2021-11-10 Bioscience Pharma Partners, LLC Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE520668A (hu) * 1956-06-28
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4868193A (en) * 1986-09-24 1989-09-19 Rorer Pharmaceutical Corporation Styryl tetrazoles and anti-allergic use thereof
KR870008853A (ko) * 1986-03-28 1987-10-21 오쯔까 아끼히꼬 하이드로퀴놀린 화합물의 제조방법
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
ZA894913B (en) * 1988-07-12 1990-03-28 Ici Pharma Heterocyclic compounds
US5089495A (en) * 1989-01-30 1992-02-18 Imperial Chemical Industries Plc Heterocyclic thiazole derivatives and pharmaceutical compositions comprising said derivatives
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
AU660742B2 (en) 1995-07-06
CA2061538A1 (en) 1993-08-20
FI925469A (fi) 1993-06-04
JPH05247036A (ja) 1993-09-24
CA2084131A1 (en) 1993-06-04
US5283252A (en) 1994-02-01
HU9203812D0 (en) 1993-03-29
AU2979892A (en) 1993-06-10
DE4139751A1 (de) 1993-06-09
EP0549879A2 (de) 1993-07-07
NZ245328A (en) 1995-02-24
ZA929330B (en) 1993-06-04
EP0549879A3 (de) 1993-07-14
FI925469A0 (fi) 1992-12-01

Similar Documents

Publication Publication Date Title
HU9303521D0 (en) Process for producing carboxylic acid derivatives and pharmaceutical compositions containing them
PH23202A (en) 2-(5-fluoronicotinoyl) acetic acid derivatives and process of preparation thereof
ZA937502B (en) Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them
HUT63632A (en) Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same
HU9202145D0 (en) Method for producing 7-aza-iso-indolinyl-quinolone derivatives and ones of naphtyridone-carboxylic acid and medical preparatives containing said compounds
HUT65204A (en) Process for producing pyrazolopyrimidine and -triazine derivatives and pharmaceutical preparations containing them
IL104446A0 (en) Acetic acid derivatives,their preparation and pharmaceutical compositions containing them
HUT44249A (en) Process for preparing ascorbic acid derivatives and pharmaceuticals comprising such compounds
HUT65486A (en) Process for producing piperidinyl methylesters of indol-3-carboxylic acid derivatives and pharmaceutical preparations containing them
IL105375A0 (en) Acetic acid derivatives,their preparation and pharmaceutical compositions containing them
HUT51277A (en) Process for producing anellated tetrahydropyridin-acetic acid derivatives and pharmaceutical compositions containing them
HUT65445A (en) Process for preparation of thiazolyl-substituted quinolinyl-methoxy-phenyl acetic acid derivatives and pharmaceuticals containing them
AU3088489A (en) Phenoxyalkylcarboxylic acid derivatives and process for their preparation
IL105100A0 (en) Glutamic acid derivatives and process for their preparation
AU649546B2 (en) Dicarboxylic acid derivatives and process for preparation thereof
HU9203867D0 (en) Method for producing benzoic acid derivatives and pharmaceutical preparatives containing them
AU1028892A (en) Phenoxyalkylcarboxylic acid derivatives and process of preparing the same
HUT44242A (en) Process for preparing substituted toluidine-benzimidazole derivatives and pharmaceuticals comprising such compounds
HU895952D0 (en) Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them
HU9203866D0 (en) Method for producing benzoic acid derivatives and pharmaceutical preparatives containing said compounds
HUT70615A (en) Process for producing acetic acid derivatives and pharmaceutical compositions containing them
HUT65850A (en) Microbiological process for preparation of 5-hydroxi-pyrazin-carbonic acid
HU9400325D0 (en) Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them
HUT49615A (en) Process for producing cefemkarboxylic acid derivatives and pharmaceutical compositions comprising same
HUT65224A (en) Process for producing alkoxymethylsubstituted pyridonbiphenyl derivatives and pharmaceutical preparations containing them

Legal Events

Date Code Title Description
DFA9 Temporary prot. cancelled due to abandonment